Minoxidil Shedding: What the Label Says, and What the Numbers Really Cover
Minoxidil Shedding:
What the Label Says,
And What the Numbers Really Cover.
The call usually comes a few weeks in. She started the foam, she did everything the box said, and now there is more hair in the drain than before she began. Most of the time this is the minoxidil shed, and it passes. But the numbers people quote about it are shakier than anyone admits, and the box and the research do not agree on how long it lasts. This is what the label actually says, what the studies measured, and the signs that mean the shedding is something else.
Extra shedding in the first weeks of minoxidil (Rogaine and its store brands) is common and usually temporary. The women's 5% foam label says hair loss “may continue for up to 2 weeks,” calls it expected and temporary, and says to see a physician if it continues after two weeks.[1] In a study of 49 patients in China who counted their shed hairs every four weeks, shedding peaked at week 4. In the 2% group, which included all the women, it was still above the starting level at week 8.[2] The best-known frequency figure, 32%, comes from oral minoxidil, where 44% of women reported a shed.[3] For the foam, I could not find a shedding rate reported by a trial. If the shedding runs past the label's two weeks, check with a doctor, and never stop a prescribed medication on your own. Shedding that is sudden, patchy, painful or tied to childbirth is a different problem.[1]
- What the minoxidil shed is
- What the box actually says
- How long minoxidil shedding lasts: the label vs the research
- How common it is, and where the numbers come from
- Is minoxidil shedding a sign it's working?
- Minoxidil shed or something else?
- When to see a doctor
- What the top search results leave out
- What I tell the women in my chair
- The evidence behind this article, graded
- Frequently asked questions
What the Minoxidil Shed Is
Minoxidil is the active ingredient in Rogaine and in the store-brand “hair regrowth treatment” foams and solutions sold next to it. Over the counter, women can buy it two ways: a 2% solution applied twice a day, or a 5% foam applied once a day.[4][1] The 5% solution is labeled for men only.[5] A randomized trial of 113 women found the once-daily foam as effective as the twice-daily solution, with less itching and dandruff.[6] Dermatologists also prescribe minoxidil as a low-dose pill, which is a different product with its own data.
The shed is the extra hair loss some people notice soon after they start, often called the “dread shed” online. The usual explanation is that minoxidil pushes resting hairs out early so new growing hairs can replace them. That idea is older and less certain than most pages suggest. A 2004 review of how minoxidil works describes the evidence. In animal studies, topical minoxidil “shortens telogen, causing premature entry of resting hair follicles into anagen, and it probably has a similar action in humans.”[7] Telogen is the resting phase. Anagen is the growing phase. “Probably” is the honest word.
Kapyderm makes no minoxidil product and sells none, and my own work is drug-free. That is why I can write this plainly. I am not trying to talk you into minoxidil or out of it. If you are using it, I want you to know what to expect, so you do not quit in week three for the wrong reason, or keep going through a shed that is really something else.
What the Box Actually Says
Many people assume the label says nothing about shedding. It does. The patient leaflet for the women's 5% foam says, word for word:
“When you first begin to use Women's Minoxidil Topical Aerosol 5% (Foam), your hair loss may continue for up to 2 weeks. This increase in hair loss is expected and is temporary. However, if it continues after two weeks, see your physician.”[1]
The women's 2% solution leaflet says the hair loss “may continue for up to 2 weeks,” that it is temporary, and to see your doctor if you continue to lose hair after two weeks.[4] The men's 5% foam goes further and adds: “This is likely a sign that you are getting rid of old hairs in order to regrow more new hairs.”[8] The women's labels I read do not include that sentence.
The same labels set the clock for results. The women's foam says results may occur at 3 months, that some women need at least 6 months, and to stop and see a doctor if there is no regrowth by then.[1] The 2% solution says at least 4 months, and that up to 8 months may be needed for the best results.[4] And on stopping: “You will probably lose your newly regrown hair in three to four months.”[1]
How Long Minoxidil Shedding Lasts: The Label vs the Research
Search “how long does minoxidil shedding last” and you will find two to four weeks, four to eight weeks, and “by month three or four,” often on pages selling the product. The label says up to two weeks. Here is what has actually been measured.
The best measurement I found is a 2025 study from a hospital in Nanjing, China.[2] Forty-nine patients with pattern hair loss, 39 men and 10 women, used 2% or 5% minoxidil twice a day for 24 weeks. Before treatment and every four weeks after, they counted their own shed hairs three ways: hairs left on paper after 30 brush strokes, hairs caught from the wash water for seven days, and hairs on the pillow overnight.
Across all patients, shedding rose significantly by week 4. From week 16 it was below where it began and kept falling to week 24.[2] Week 8 is where it gets less tidy: the paper's results section says shedding was still above the starting level then, while its discussion says it had returned to baseline. Both sections agree on the group that matters most here. The 2% group shed for longer, with shedding above the starting level at both week 4 and week 8, while the 5% group had dropped below its starting level by week 8. All 10 women in the study used the 2% solution.[2]
The oral data point the same way. In a Brazilian study of 435 people prescribed low-dose oral minoxidil, those who shed said it lasted 1.5 months on average, and 1.6 months for the women.[3] That is memory, reported over the phone, about a pill. But it is weeks, not days.
So the box's two weeks is the short end. In the one study that counted, the increase ran past it, especially on the 2% solution. That gap matters, because a woman who reads “up to 2 weeks” and is still shedding at week five tends to conclude the product is making her worse.
The Nanjing study is small and has no control group. It excluded people with telogen effluvium, recent pregnancy, anemia, hormone disorders or severe stress, which helps, but nothing controlled for the season. Patients counted their own hairs. It reports group averages only, not how many patients shed, and its results and discussion disagree about week 8. Only 10 of the 49 were women, all on 2%.[2] The often-quoted “begins at 2 to 4 weeks, lasts 3 to 6 weeks” appears in a 2024 NYU paper, but there it is cited from a textbook chapter and an older review, not measured by the authors.[9] A 2025 report in the Journal of the American Academy of Dermatology opens by saying that systematic evaluation of this shed “remains scarce.”[10] Nobody has measured it in a large group of women on the foam.
How Common It Is, and Where the Numbers Come From
This is where the numbers people quote fall apart. The large randomized trials of minoxidil in women report itching and irritation in their published summaries, and one found more unwanted hair growth on the 5% solution, but neither gives a shedding rate.[6][11] A 2021 paper puts temporary shedding at the start of topical treatment at up to 17.5%, citing the 2011 trial in women.[3] That trial's full text is behind a paywall, and I could not confirm the figure at its source.
What I could open is patient report, from outside the US:
- 9.8% reported “increased hair loss” in a review of 400 patients prescribed topical minoxidil at a clinic in Jeddah, Saudi Arabia, two-thirds of them women.[12]
- In 200 men starting minoxidil in Indore, India, 11% reported increased shedding, and another 14% reported shedding together with scalp dryness.[13]
The best-known percentage comes from the pill. In Brazil, 435 people prescribed low-dose oral minoxidil at three hair clinics answered a telephone interview about side effects. 32% reported shedding at the start of treatment: 44% of the women and 21% of the men. Having used 5% foam just before was not linked to who shed, and only 3 of the 435 stopped the pill because of it.[3]
At NYU, a chart review of 115 patients starting low-dose oral minoxidil, 55% of them women, found a new shed recorded in 6 of 115 (5.2%). The authors called that “lower than previously reported in literature.” They cite earlier oral studies with rates from 2.4% to 22%.[9] The Brazilian team asked every patient directly, and suggested that asking, rather than waiting for complaints, explains why their side-effect rates ran higher than earlier studies.[3] The NYU figure counts only what made it into a chart. Both are pill figures. They tell you little about a foam you apply to the scalp.
Most people who shed early on minoxidil stop shedding. In the Nanjing study, shedding fell below its starting level from week 16.[2] In the Brazilian oral study, only 3 of 435 stopped because of shedding.[3] In the NYU review, keeping the topical going while starting the pill made no significant difference to who shed: 2 of 37 with the overlap against 4 of 78 without.[9] Now the counter-evidence: in the Saudi clinic review, 86.3% of the 400 patients had stopped minoxidil.[12] Shedding was not the only reason, but it was among the side effects they reported. The 2025 JAAD report says the shed “frequently leads to patient anxiety and treatment discontinuation.”[10] And because none of these studies had a comparison group to separate the minoxidil shed from other causes, “it will pass” is a likelihood, not a promise.
Is Minoxidil Shedding a Sign It's Working?
Sellers say yes. Some dermatologists say early shedding does not prove anything. The evidence sits in between.
The Nanjing study is the only one I found that tested it. In the 5% group, a bigger early shed went with better results on trichoscopy at 24 weeks, including hair density (r = 0.492). In the 2% group, which included all the women, there was no significant link between the shed and those trichoscopy measures.[2] Both groups did show a link between a bigger shed and a better score on the overall severity scale the doctors used, and among the 10 women that link was strong.[2] The authors concluded the amount of shedding is a “potential” marker of treatment response.
That is a correlation in a small study. Only 43 of the 49 had the final scalp exam, and the 5% result rests on about 16 men.[2] For women, the evidence is thinnest of all: 10 women, all on the 2% solution. It does not mean a shed guarantees regrowth, and it does not mean that no shed means failure. In the Brazilian oral survey, about two-thirds never reported one.[3] I tell clients the same thing: a shed in the first weeks is consistent with the treatment taking hold. It is not proof, and it is not a reason to ignore the label's two weeks.
Minoxidil Shed or Something Else?
This is the section I most want you to read. Women rarely start minoxidil in a calm year. They start it because something already made their hair fall out, and that something may still be running. The label itself lists hair loss the product “will not prevent or improve.” That includes hair loss related to pregnancy, some medications, very low body iron, too much vitamin A, recently stopping birth control pills, an underactive thyroid, chemotherapy, and diseases that scar the scalp.[1]
| Type of shedding | When it starts | What points to it | What to do |
|---|---|---|---|
| Minoxidil start-up shed | In the first weeks of use; in the Nanjing study, peaking at week 4, and still raised at week 8 on the 2% solution[2] | It began after you started, on a scalp that is not sore or red | The label says see a physician if it continues after two weeks[1] |
| Telogen effluvium after a trigger | Generally 8 to 12 weeks after a major illness, surgery or pregnancy; usually resolves within 3 to 6 months[14] | A fever, surgery, crash diet, new medication or major stress two to three months before | Find the trigger; a doctor for blood work if iron or thyroid is in question |
| Shedding after childbirth | In the months after the birth | A baby in the past year | The women's labels say do not use minoxidil if hair loss is associated with childbirth[1] |
| Sudden or patchy loss | Any time, often quickly | Round patches, or loss outside the usual thinning area | The label says do not use if hair loss is sudden and/or patchy; see a doctor[1] |
| Shedding months into treatment | After the first few months, once early shedding had settled | Not the start-up shed: in the Nanjing study shedding was below the starting level from week 16[2] | Look for a new trigger, and a doctor if it continues |
Telogen effluvium is the one I see mistaken for the minoxidil shed most often, because the timing overlaps. A shed triggered by pregnancy, a major illness or complicated surgery generally begins 8 to 12 weeks after the trigger and resolves within 3 to 6 months.[14] If you started minoxidil because of a shed, the shed you see in week four may be the one you already had. I explain how to find the trigger in my guide to diffuse hair loss and telogen effluvium.
The season is the other trap. Starting minoxidil in late summer or fall means the start-up shed lands on top of the shed many people already notice at this time of year. I covered that in my guide to seasonal hair shedding. And if you had a baby in the past year, read my postpartum hair loss guide before you reach for the foam, because the label tells you not to.
Minoxidil for telogen effluvium itself is off-label. A 2025 Japanese trial of 5% minoxidil in 12 patients with telogen effluvium reported more thick hairs on scalp photographs. But it had no comparison group, and it was funded by a company that sells minoxidil in Japan. The authors themselves called the use off-label and noted that telogen effluvium tends to settle on its own.[15]
When to See a Doctor
The label is clear on these, and so am I. If any of them apply, stop and see a doctor rather than waiting out the shed.
Read the fourth point again. “You do not know the reason for your hair loss” is on the do-not-use list.[1] The product's own label says the cause should be known before you start. That is what an assessment is for, and when the cause may be medical, what a doctor is for.
What the Top Search Results Leave Out
Before writing this, I read the pages that come up for “minoxidil shedding” and “how long does minoxidil shedding last.” Most are written by companies that sell minoxidil. The best of them quotes the label and the studies above. Three things were still missing.
They give you a number of weeks without telling you why the numbers disagree. The label's two weeks, the textbook's three to six, and the Nanjing counts, raised through week 8 on the 2% solution, are three different kinds of number. Only one was counted.[1][9][2]
They quote pill numbers to people using foam. The 32% that one of the top pages gives is from oral minoxidil, and that page does say so.[3] For the foam, I could not find a trial figure, and saying so is more useful than borrowing one. None of the top pages I could read mentions that in the same study, 44% of the women shed.
They do not tell you what else the shed might be. “Push through, it means it's working” is fine advice for the start-up shed. It is poor advice for a postpartum shed, a thyroid problem or patchy loss, which the label itself rules out.[1]
What I Tell the Women in My Chair
Write down the start date, and take photos. Same spots, same light, the day you start, then every four weeks. Shedding feels endless from inside it. A dated photo of your part is a better ruler than the drain.
Note what else happened in the three months before. An illness, a birth, a new medication, a diet, a hard stretch at work. If any of those are on the list, the shed may not be the minoxidil.
Follow the label, not the forums. If the shedding is still going after two weeks, call your doctor.[1] Often the answer will be to keep going. The point is that someone qualified decides.
If your minoxidil is prescribed, never stop a prescribed medication on your own. The pill in particular belongs with the doctor who prescribed it. And whichever form you use, stopping means the regrown hair is likely to go within three to four months, by the label's own words.[1]
Give it the time the label asks for. Three to six months for the women's foam, at least four for the 2% solution, before judging whether it works.[1][4]
When I see a client in the middle of a shed, I look at the scalp under magnification. Short new hairs coming up through the part, and hairs of uneven thickness, tell different stories. That is an assessment of the scalp and hair rather than a medical diagnosis, and if the picture points to something medical, my job is to send you to a doctor. I explain what that visit involves in what a trichologist's scalp assessment can tell you.
Kapyderm's scalp care is plant-based and contains no minoxidil. If you are using minoxidil, ask your doctor before adding anything else to the same area, since the label says not to use it alongside other medicines on the scalp.[1] No controlled trial of any Kapyderm product in minoxidil-related shedding exists, and none is implied. If you want a drug-free option for pattern thinning, I describe what the pattern hair loss home treatment does and does not do on its own page.
The Evidence Behind This Article, Graded
Not every claim above rests on the same quality of evidence. Here is what each one is actually standing on.
Supported, in a small study
Counted every four weeks in 49 patients: up at week 4, still raised at week 8 on the 2% solution, below the starting level from week 16.[2] The limit: no control group, self-counted hairs, only 10 women, and the paper is inconsistent about week 8 overall.
The label's figure, not a measurement
Stated on the women's and men's labels.[1][8] The limit: the one study that counted found the increase lasting longer.[2] Treat two weeks as the point to check in with a doctor, not as the end of the shed.
Weak, early evidence
A correlation on trichoscopy in the 5% group of one 49-patient study, resting on about 16 men, and none on trichoscopy in the 2% group that included all the women.[2] The limit: a correlation, in a small, uncontrolled study.
Patient report only
9.8% of 400 in Saudi Arabia, and 11% plus 14% with dryness in 200 Indian men.[12][13] The limit: self-reported, outside the US, and not from controlled trials. The 17.5% trial figure I could not confirm at its source.[3]
Supported, by recall
32% of 435 in a telephone survey, 44% of the women.[3] The limit: the authors list a retrospective design and selection bias, and a chart review at NYU found 5.2%.[9] How you ask changes the answer.
Plausible, mostly from animal work
Shown in animal studies and described as probable in humans.[7] The limit: the human mechanism behind the shed has not been directly proven.
The honest gaps
I found no controlled study that measures how many women on the over-the-counter foam shed, or for how long. The label's two weeks is not backed by a count I could find. The best count is 49 patients with no control group, and the best-known frequency figure is from the pill.[2][3] A 2025 multicenter study of exactly this question is behind a paywall, and I have not used any figure from it.[10] Anyone who quotes you a precise percentage for the foam is quoting something else.
Frequently Asked Questions
- Aurohealth LLC. Women's Minoxidil Topical Aerosol 5% (Foam), drug label and patient leaflet. DailyMed, U.S. National Library of Medicine; label effective September 15, 2026. dailymed.nlm.nih.gov. Source for the shedding sentence, results timing, the do-not-use and stop-use lists, pregnancy wording, what happens on stopping, and the hair loss the product will not improve. Women's Rogaine 5% foam carries the same Drug Facts.
- Bi L, Kan H, Wang J, Ding Y, Huang Y, Wang C, Du Y, Lu C, Zhao M, Sun W, Su T, Fan W. Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients. Journal of Dermatological Treatment. 2025;36(1):2480739. doi:10.1080/09546634.2025.2480739. PMID 40122142. 49 patients (39 men, 10 women) at the First Affiliated Hospital of Nanjing Medical University, China, January to June 2023; 2% or 5% minoxidil twice daily for 24 weeks; shedding self-counted every four weeks; no control group. Funded by the National Natural Science Foundation of China and a Jiangsu provincial grant; no conflicts reported.
- Sanabria B, Vanzela TN, Miot HA, Müller Ramos P. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. Journal of the American Academy of Dermatology. 2021;84(4):1175–1178. doi:10.1016/j.jaad.2020.11.035. Research letter. 435 patients (215 women) prescribed low-dose oral minoxidil at 3 hair clinics in Brazil, January 2017 to May 2020, interviewed by telephone. No conflicts disclosed. Also the source for the up-to-17.5% topical figure, which it attributes to the 2011 trial in women.
- L. Perrigo Company. GoodSense Hair Regrowth Treatment (Minoxidil Topical Solution USP 2%, for women), drug label and patient leaflet. DailyMed; label effective August 6, 2026. dailymed.nlm.nih.gov. Source for the 2% shedding sentence, twice-daily use and results timing.
- Kenvue. Men's Rogaine Extra Strength 5% Minoxidil Topical Solution, drug label. DailyMed; label effective September 6, 2024. dailymed.nlm.nih.gov. Source for “For use by men only.”
- Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Journal of the American Academy of Dermatology. 2011;65(6):1126–1134.e2. PMID 21700360. doi:10.1016/j.jaad.2010.09.724. 113 women, Berlin, 24 weeks. Abstract read; full text paywalled.
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186–194. PMID 14996087. doi:10.1111/j.1365-2133.2004.05785.x. Review.
- Aurohealth LLC. Minoxidil Topical Aerosol 5% (Foam) for men, drug label and patient leaflet. DailyMed; label effective September 28, 2026. dailymed.nlm.nih.gov. Source for the men's shedding sentence.
- Nohria A, Desai D, Sikora M, Mandal S, Shapiro J, Lo Sicco K. Combating “dread shed”: the impact of overlapping topical and oral minoxidil on temporary hair shedding during oral minoxidil initiation. JAAD International. 2024;15:220–224. PMC11067493. doi:10.1016/j.jdin.2024.03.005. Retrospective chart review of 115 patients starting low-dose oral minoxidil at NYU Langone, New York, 2008 to 2023; shedding self-reported in medical records. No funding; two authors report consulting for pharmaceutical companies.
- Zhang Y, Wu L, Zhao W, et al. Monitoring and evaluation of temporary increase in hair shedding induced by topical minoxidil in androgenetic alopecia: a multicenter prospective cohort study. Journal of the American Academy of Dermatology. 2025;93(6):1602–1604. doi:10.1016/j.jaad.2025.08.025. PMID 40835129. Brief report from China; only its opening paragraph is quoted here, because the full text is paywalled.
- Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology. 2004;50(4):541–553. PMID 15034503. doi:10.1016/j.jaad.2003.06.014. 381 women, 48 weeks; the published abstract reports itching, irritation and unwanted hair growth but no shedding rate.
- Shadi Z. Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatology and Therapy. 2023;13(5):1157–1169. PMC10149432. doi:10.1007/s13555-023-00919-x. Retrospective study of 400 patients (66.5% women) in Jeddah, Saudi Arabia; side effects self-reported. No funding.
- Shukla N, Jaiswal CS, Nagwanshi J, Dandotiya D, Sharma R. Early trichoscopic changes of minoxidil therapy in male pattern hair loss: a prospective cohort study. Journal of Pharmacy and Bioallied Sciences. 2026;18(2):108–111. PMC13086379. doi:10.4103/jpbs.jpbs_1711_24. 200 men aged 18 to 40, Indore, India, February 2019 to August 2020; side effects self-reported.
- Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Research. 2017;6:1650. PMC5676194. doi:10.12688/f1000research.11775.1. Source for the usual timing of telogen effluvium after a trigger.
- Ohyama M, Irisawa R, Uchiyama M, Mori M, Aoki K, Ueda Y, Fujita T. Use of 5% topical minoxidil application for telogen effluvium: an open-label single-arm clinical trial. Journal of Dermatology. 2025;52(9):1351–1359. PMC12411807. doi:10.1111/1346-8138.17844. 12 patients, Japan, 24 weeks, no comparison group; funded by Taisho Pharmaceutical.
Shedding on Minoxidil?
Find Out Which Shed It Is.
If your shedding has run past the label's two weeks, if it started before the minoxidil did, or if your part keeps widening, that is worth a closer look. I assess the scalp under magnification, record what I see so the next visit has something to compare against, and refer to a physician when that is what the picture calls for. If you have chest pain, a racing heart, swelling, or a red and painful scalp, see a doctor first.
